A novel recombinant 6Aβ15-THc-C chimeric vaccine (rCV02) mitigates Alzheimer's disease-like pathology, cognitive decline and synaptic loss in aged 3 × Tg-AD mice.

Sci Rep · 2016 · PMC4891678 · PMID 27255752

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The prophylactic treatment of 3-month-old 3 × Tg-AD mice showed a trend toward the generation and maintenance of relatively stable and adequate antibody levels over a 7-month period after the last vaccination.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.